Loomis Sayles & CO L P Regeneron Pharmaceuticals, Inc. Transaction History

Loomis Sayles & CO L P

  • $79.2 Billion
  • Q4 2024

A detailed history of Loomis Sayles & CO L P transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Loomis Sayles & CO L P holds 1,575,349 shares of REGN stock, worth $1.1 Billion. This represents 1.42% of its overall portfolio holdings.

Number of Shares
1,575,349
Previous 1,181,352 33.35%
Holding current value
$1.1 Billion
Previous $1.24 Billion 9.64%
% of portfolio
1.42%
Previous 1.63%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$701.85 - $1046.91 $277 Million - $412 Million
393,997 Added 33.35%
1,575,349 $1.12 Billion
Q3 2024

Nov 13, 2024
SELL
$1024.09 - $1201.76 $36.4 Million - $42.7 Million
-35,504 Reduced 2.92%
1,181,352 $1.24 Billion
Q2 2024

Aug 13, 2024
BUY
$883.2 - $1071.19 $8.53 Million - $10.3 Million
9,661 Added 0.8%
1,216,856 $1.28 Billion
Q1 2024

May 14, 2024
SELL
$902.69 - $993.35 $10.7 Million - $11.8 Million
-11,872 Reduced 0.97%
1,207,195 $1.16 Billion
Q4 2023

Feb 13, 2024
SELL
$775.18 - $881.7 $10.7 Million - $12.2 Million
-13,812 Reduced 1.12%
1,219,067 $1.07 Billion
Q3 2023

Nov 09, 2023
SELL
$692.45 - $844.37 $30.9 Million - $37.7 Million
-44,605 Reduced 3.49%
1,232,879 $1.01 Billion
Q2 2023

Aug 11, 2023
SELL
$700.03 - $830.35 $24.4 Million - $29 Million
-34,923 Reduced 2.66%
1,277,484 $918 Million
Q1 2023

May 11, 2023
SELL
$680.49 - $826.97 $17.2 Million - $20.9 Million
-25,274 Reduced 1.89%
1,312,407 $1.08 Billion
Q4 2022

Feb 10, 2023
SELL
$705.89 - $766.39 $267 Million - $290 Million
-378,936 Reduced 22.07%
1,337,681 $965 Million
Q3 2022

Nov 14, 2022
SELL
$573.97 - $724.32 $27.6 Million - $34.9 Million
-48,171 Reduced 2.73%
1,716,617 $1.18 Billion
Q2 2022

Aug 05, 2022
SELL
$548.35 - $738.84 $430 Million - $579 Million
-783,259 Reduced 30.74%
1,764,788 $1.04 Billion
Q1 2022

May 13, 2022
SELL
$595.12 - $698.43 $48.3 Million - $56.6 Million
-81,104 Reduced 3.08%
2,548,047 $1.78 Billion
Q4 2021

Feb 14, 2022
SELL
$543.48 - $670.97 $69.3 Million - $85.6 Million
-127,584 Reduced 4.63%
2,629,151 $1.66 Billion
Q3 2021

Nov 12, 2021
BUY
$574.03 - $680.96 $1.44 Million - $1.71 Million
2,511 Added 0.09%
2,756,735 $1.67 Billion
Q2 2021

Aug 13, 2021
SELL
$472.8 - $558.54 $57.7 Million - $68.2 Million
-122,144 Reduced 4.25%
2,754,224 $1.54 Billion
Q1 2021

May 17, 2021
SELL
$446.73 - $548.2 $39.4 Million - $48.4 Million
-88,215 Reduced 2.98%
2,876,368 $1.36 Billion
Q4 2020

Feb 12, 2021
SELL
$478.3 - $607.98 $101 Million - $129 Million
-211,415 Reduced 6.66%
2,964,583 $1.43 Billion
Q3 2020

Nov 12, 2020
SELL
$544.75 - $658.21 $45.6 Million - $55.1 Million
-83,700 Reduced 2.57%
3,175,998 $1.78 Billion
Q2 2020

Aug 14, 2020
SELL
$493.32 - $643.92 $115 Million - $150 Million
-233,115 Reduced 6.67%
3,259,698 $2.03 Billion
Q1 2020

May 15, 2020
SELL
$336.18 - $494.43 $67.2 Million - $98.8 Million
-199,862 Reduced 5.41%
3,492,813 $1.71 Billion
Q4 2019

Feb 14, 2020
BUY
$274.13 - $376.51 $27.7 Million - $38 Million
100,878 Added 2.81%
3,692,675 $1.39 Billion
Q3 2019

Nov 13, 2019
BUY
$273.46 - $318.39 $85.2 Million - $99.2 Million
311,476 Added 9.5%
3,591,797 $996 Million
Q2 2019

Aug 14, 2019
BUY
$299.6 - $414.82 $31 Million - $43 Million
103,634 Added 3.26%
3,280,321 $1.03 Billion
Q1 2019

May 15, 2019
BUY
$372.08 - $439.57 $5.78 Million - $6.83 Million
15,540 Added 0.49%
3,176,687 $1.3 Billion
Q4 2018

Feb 14, 2019
SELL
$335.82 - $403.04 $62.2 Million - $74.6 Million
-185,133 Reduced 5.53%
3,161,147 $1.18 Billion
Q3 2018

Nov 13, 2018
BUY
$351.14 - $408.51 $14.4 Million - $16.8 Million
41,138 Added 1.24%
3,346,280 $1.35 Billion
Q2 2018

Aug 14, 2018
BUY
$284.6 - $344.99 $138 Million - $167 Million
485,387 Added 17.21%
3,305,142 $1.14 Billion
Q1 2018

May 11, 2018
BUY
$315.82 - $393.78 $227 Million - $283 Million
718,144 Added 34.17%
2,819,755 $971 Million
Q4 2017

Feb 14, 2018
BUY
$358.63 - $469.95 $83 Million - $109 Million
231,560 Added 12.38%
2,101,611 $790 Million
Q3 2017

Nov 14, 2017
BUY
$431.38 - $504.0 $20.6 Million - $24.1 Million
47,755 Added 2.62%
1,870,051 $836 Million
Q2 2017

Aug 14, 2017
BUY
N/A
1,822,296
1,822,296 $895 Million

Others Institutions Holding REGN

# of Institutions
1,487
Shares Held
85.7M
Call Options Held
1.53M
Put Options Held
1.43M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $74.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Loomis Sayles & CO L P Portfolio

Follow Loomis Sayles & CO L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email